Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration
Authors:
- Andrea PaganiAPAndrea Pagani
- Dominik ThorDominik Thor
- Adriana C. PanayiAdriana C. Panayi
- Silvan M. KleinSilvan M. Klein
- Sebastian GeisSGSebastian Geis
- Leonard KnoedlerLKLeonard Knoedler
- Samuel KnoedlerSKSamuel Knoedler
- Filippo A. G. PerozzoFPFilippo A. G. Perozzo
- Giuseppe SofoGSGiuseppe Sofo
- Rafael LoucasRLRafael Loucas
- Lukas PrantlLukas Prantl
- Dominik DuscherDominik Duscher
Open Access
- 21 March 2025
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (7) , 2133
Abstract
Autoimmune-induced alopecia, such as alopecia areata, involves immune-mediated damage to hair follicles, leading to significant hair loss. Emerging therapies that stabilize hypoxia-inducible factor 1-alpha (HIF-1α) show promise in counteracting follicular degradation and supporting hair regrowth. This communication highlights the potential of iron chelators, specifically deferoxamine (DFO) and deferiprone (DFP), to stabilize HIF-1α by reducing iron availability, thereby promoting vascularization, cellular proliferation, and a regenerative environment in the hair follicle niche. Clinical trials with iron chelators demonstrated improvements in hair density, thickness, and elasticity, as well as a reduction in hair loss by up to 66.8% over six months. These findings underscore the therapeutic potential of iron chelators in autoimmune alopecia management. Future research should explore the synergistic use of iron chelators with immune-modulating therapies, positioning them as viable options in the evolving field of alopecia treatment.Keywords
This publication has 15 references indexed in Scilit:
- Janus Kinase Inhibitors for Alopecia AreataJAMA Network Open, 2023
- Prolonged Drug-Induced Hypersensitivity Syndrome/DRESS With Alopecia Areata and Autoimmune ThyroiditisFederal Practitioner, 2022
- Two Phase 3 Trials of Baricitinib for Alopecia AreataNew England Journal of Medicine, 2022
- The JAK/STAT signaling pathway: from bench to clinicSignal Transduction and Targeted Therapy, 2021
- Rosacea: New Concepts in Classification and TreatmentAmerican Journal of Clinical Dermatology, 2021
- Deferiprone Stimulates Aged Dermal Fibroblasts via HIF-1α ModulationAesthetic Surgery Journal, 2020
- Alopecia areataNature Reviews Disease Primers, 2017
- PsoriasisThe Lancet, 2015
- Hepcidin and iron homeostasisBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
- Epidermal Stem Cells of the SkinAnnual Review of Cell and Developmental Biology, 2006